280 related articles for article (PubMed ID: 32817456)
21. Molecular differentiation and antifungal susceptibility of Candida albicans isolated from patients with respiratory infections in Guiyang Medical College Hospital, China.
Liu Y; Kang Y; Yokoyama K; Gonoi T; Mikami Y
Nihon Ishinkin Gakkai Zasshi; 2009; 50(3):175-8. PubMed ID: 19654451
[TBL] [Abstract][Full Text] [Related]
22. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
Jensen RH
Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
[TBL] [Abstract][Full Text] [Related]
23. Rapid detection of ERG11 gene mutations in clinical Candida albicans isolates with reduced susceptibility to fluconazole by rolling circle amplification and DNA sequencing.
Wang H; Kong F; Sorrell TC; Wang B; McNicholas P; Pantarat N; Ellis D; Xiao M; Widmer F; Chen SC
BMC Microbiol; 2009 Aug; 9():167. PubMed ID: 19682357
[TBL] [Abstract][Full Text] [Related]
24. Rep1p negatively regulating MDR1 efflux pump involved in drug resistance in Candida albicans.
Chen CG; Yang YL; Tseng KY; Shih HI; Liou CH; Lin CC; Lo HJ
Fungal Genet Biol; 2009 Sep; 46(9):714-20. PubMed ID: 19527793
[TBL] [Abstract][Full Text] [Related]
25. Beauvericin Potentiates Azole Activity via Inhibition of Multidrug Efflux, Blocks Candida albicans Morphogenesis, and Is Effluxed via Yor1 and Circuitry Controlled by Zcf29.
Shekhar-Guturja T; Tebung WA; Mount H; Liu N; Köhler JR; Whiteway M; Cowen LE
Antimicrob Agents Chemother; 2016 Dec; 60(12):7468-7480. PubMed ID: 27736764
[TBL] [Abstract][Full Text] [Related]
26. PAP1 [poly(A) polymerase 1] homozygosity and hyperadenylation are major determinants of increased mRNA stability of CDR1 in azole-resistant clinical isolates of Candida albicans.
Manoharlal R; Gorantala J; Sharma M; Sanglard D; Prasad R
Microbiology (Reading); 2010 Feb; 156(Pt 2):313-326. PubMed ID: 19910410
[TBL] [Abstract][Full Text] [Related]
27. Monitoring Antifungal Resistance in a Global Collection of Invasive Yeasts and Molds: Application of CLSI Epidemiological Cutoff Values and Whole-Genome Sequencing Analysis for Detection of Azole Resistance in Candida albicans.
Castanheira M; Deshpande LM; Davis AP; Rhomberg PR; Pfaller MA
Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784671
[TBL] [Abstract][Full Text] [Related]
28. Interaction of Candida albicans biofilms with antifungals: transcriptional response and binding of antifungals to beta-glucans.
Vediyappan G; Rossignol T; d'Enfert C
Antimicrob Agents Chemother; 2010 May; 54(5):2096-111. PubMed ID: 20194705
[TBL] [Abstract][Full Text] [Related]
29. Antifungal drug resistance in pathogenic fungi.
Vanden Bossche H; Dromer F; Improvisi I; Lozano-Chiu M; Rex JH; Sanglard D
Med Mycol; 1998; 36 Suppl 1():119-28. PubMed ID: 9988500
[TBL] [Abstract][Full Text] [Related]
30. Group I intron renders differential susceptibility of Candida albicans to Bleomycin.
Jayaguru P; Raghunathan M
Mol Biol Rep; 2007 Mar; 34(1):11-7. PubMed ID: 17115251
[TBL] [Abstract][Full Text] [Related]
31. Overexpression and mutation as a genetic mechanism of fluconazole resistance in Candida albicans isolated from human immunodeficiency virus patients in Indonesia.
Rosana Y; Yasmon A; Lestari DC
J Med Microbiol; 2015 Sep; 64(9):1046-1052. PubMed ID: 26297039
[TBL] [Abstract][Full Text] [Related]
32. FLO8 deletion leads to azole resistance by upregulating CDR1 and CDR2 in Candida albicans.
Li WJ; Liu JY; Shi C; Zhao Y; Meng LN; Wu F; Xiang MJ
Res Microbiol; 2019; 170(6-7):272-279. PubMed ID: 31449848
[TBL] [Abstract][Full Text] [Related]
33. Nucleotide substitutions in the Candida albicans ERG11 gene of azole-susceptible and azole-resistant clinical isolates.
Strzelczyk JK; Slemp-Migiel A; Rother M; Gołąbek K; Wiczkowski A
Acta Biochim Pol; 2013; 60(4):547-52. PubMed ID: 24340302
[TBL] [Abstract][Full Text] [Related]
34. Genotypic and phenotypic characterization of Candida albicans Lebanese hospital isolates resistant and sensitive to caspofungin.
Toutounji M; Tokajian S; Khalaf RA
Fungal Genet Biol; 2019 Jun; 127():12-22. PubMed ID: 30794951
[TBL] [Abstract][Full Text] [Related]
35. The Vacuolar Ca
Luna-Tapia A; DeJarnette C; Sansevere E; Reitler P; Butts A; Hevener KE; Palmer GE
mSphere; 2019 Feb; 4(1):. PubMed ID: 30728284
[TBL] [Abstract][Full Text] [Related]
36. Global analysis of genetic circuitry and adaptive mechanisms enabling resistance to the azole antifungal drugs.
Mount HO; Revie NM; Todd RT; Anstett K; Collins C; Costanzo M; Boone C; Robbins N; Selmecki A; Cowen LE
PLoS Genet; 2018 Apr; 14(4):e1007319. PubMed ID: 29702647
[TBL] [Abstract][Full Text] [Related]
37. An update on antifungal targets and mechanisms of resistance in Candida albicans.
Akins RA
Med Mycol; 2005 Jun; 43(4):285-318. PubMed ID: 16110776
[TBL] [Abstract][Full Text] [Related]
38. Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene.
Sanglard D; Ischer F; Monod M; Bille J
Microbiology (Reading); 1997 Feb; 143 ( Pt 2)():405-416. PubMed ID: 9043118
[TBL] [Abstract][Full Text] [Related]
39. High-Throughput Chemical Screen Identifies a 2,5-Disubstituted Pyridine as an Inhibitor of Candida albicans Erg11.
Du Bois AC; Xue A; Pham C; Revie NM; Meyer KJ; Yashiroda Y; Boone C; Nodwell JR; Stogios P; Savchenko A; Robbins N; Iyer KR; Cowen LE
mSphere; 2022 Jun; 7(3):e0007522. PubMed ID: 35531664
[TBL] [Abstract][Full Text] [Related]
40. Emergence of Antifungal Resistant Subclades in the Global Predominant Phylogenetic Population of Candida albicans.
Gong J; Chen XF; Fan X; Xu J; Zhang H; Li RY; Chen SC; Kong F; Zhang S; Sun ZY; Kang M; Liao K; Guo DW; Wan Z; Hu ZD; Chu YZ; Zhao HM; Zou GL; Shen C; Geng YY; Wu WW; Wang H; Zhao F; Lu X; He LH; Liu GM; Xu YC; Zhang JZ; Xiao M
Microbiol Spectr; 2023 Feb; 11(1):e0380722. PubMed ID: 36700687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
